Banu Arun

Association analysis identifies 65 new breast cancer risk loci

Kyriaki Michailidou, Sara Lindström, Joe Dennis et al. · Nature · 2017 · 1.5K citations · Full text

Epidemiology, Breast Oncology, Cancer Risk +8

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

Shiping Jiao, Weiya Xia, Hirohito Yamaguchi et al. · Clinical Cancer Research · 2017 · 943 citations · Full text

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

Mark E. Robson, Angela R. Bradbury, Banu Arun et al. · Journal of Clinical Oncology · 2015 · 934 citations

Genetic Testing, Cancer Pathology, Genetics +27

Clinical and Pathologic Characteristics of Patients With <i>BRCA</i>-Positive and <i>BRCA</i>-Negative Breast Cancer

Deann P. Atchley, Constance T. Albarracin, Adriana López et al. · Journal of Clinical Oncology · 2008 · 599 citations · Full text